[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Tyrosine Protein Kinase JAK1 Market Growth 2022-2028

January 2022 | 111 pages | ID: G89ED57B6641EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Tyrosine Protein Kinase JAK1 will have significant change from previous year. According to our (LP Information) latest study, the global Tyrosine Protein Kinase JAK1 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Tyrosine Protein Kinase JAK1 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Tyrosine Protein Kinase JAK1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Tyrosine Protein Kinase JAK1 market, reaching US$ million by the year 2028. As for the Europe Tyrosine Protein Kinase JAK1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Tyrosine Protein Kinase JAK1 players cover AbbVie Inc, Aclaris Therapeutics Inc, Astellas Pharma Inc, and AstraZeneca Plc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Tyrosine Protein Kinase JAK1 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • AZD-4205
  • Baricitinib
  • Cerdulatinib
  • CJ-15314
  • Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Cutaneous Lupus Erythematosus
  • Eosinophilia
  • Hairy Cell Leukemia
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • AbbVie Inc
  • Aclaris Therapeutics Inc
  • Astellas Pharma Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • Chipscreen Biosciences Ltd
  • CJ HealthCare Corp
  • Concert Pharmaceuticals Inc
  • Eli Lilly and Co
  • Galapagos NV
  • Incyte Corp
  • Japan Tobacco Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Nissan Chemical Industries Ltd
  • Pfizer Inc
  • Portola Pharmaceuticals Inc
  • Sareum Holdings Plc
  • Theravance Biopharma Inc
  • Vectura Group Plc
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tyrosine Protein Kinase JAK1 Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Tyrosine Protein Kinase JAK1 by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Tyrosine Protein Kinase JAK1 by Country/Region, 2017, 2022 & 2028
2.2 Tyrosine Protein Kinase JAK1 Segment by Type
  2.2.1 AZD-4205
  2.2.2 Baricitinib
  2.2.3 Cerdulatinib
  2.2.4 CJ-15314
  2.2.5 Others
2.3 Tyrosine Protein Kinase JAK1 Sales by Type
  2.3.1 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)
  2.3.2 Global Tyrosine Protein Kinase JAK1 Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Tyrosine Protein Kinase JAK1 Sale Price by Type (2017-2022)
2.4 Tyrosine Protein Kinase JAK1 Segment by Application
  2.4.1 Cutaneous Lupus Erythematosus
  2.4.2 Eosinophilia
  2.4.3 Hairy Cell Leukemia
  2.4.4 Others
2.5 Tyrosine Protein Kinase JAK1 Sales by Application
  2.5.1 Global Tyrosine Protein Kinase JAK1 Sale Market Share by Application (2017-2022)
  2.5.2 Global Tyrosine Protein Kinase JAK1 Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Tyrosine Protein Kinase JAK1 Sale Price by Application (2017-2022)

3 GLOBAL TYROSINE PROTEIN KINASE JAK1 BY COMPANY

3.1 Global Tyrosine Protein Kinase JAK1 Breakdown Data by Company
  3.1.1 Global Tyrosine Protein Kinase JAK1 Annual Sales by Company (2020-2022)
  3.1.2 Global Tyrosine Protein Kinase JAK1 Sales Market Share by Company (2020-2022)
3.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue by Company (2020-2022)
  3.2.1 Global Tyrosine Protein Kinase JAK1 Revenue by Company (2020-2022)
  3.2.2 Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company (2020-2022)
3.3 Global Tyrosine Protein Kinase JAK1 Sale Price by Company
3.4 Key Manufacturers Tyrosine Protein Kinase JAK1 Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Tyrosine Protein Kinase JAK1 Product Location Distribution
  3.4.2 Players Tyrosine Protein Kinase JAK1 Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR TYROSINE PROTEIN KINASE JAK1 BY GEOGRAPHIC REGION

4.1 World Historic Tyrosine Protein Kinase JAK1 Market Size by Geographic Region (2017-2022)
  4.1.1 Global Tyrosine Protein Kinase JAK1 Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue by Geographic Region
4.2 World Historic Tyrosine Protein Kinase JAK1 Market Size by Country/Region (2017-2022)
  4.2.1 Global Tyrosine Protein Kinase JAK1 Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue by Country/Region
4.3 Americas Tyrosine Protein Kinase JAK1 Sales Growth
4.4 APAC Tyrosine Protein Kinase JAK1 Sales Growth
4.5 Europe Tyrosine Protein Kinase JAK1 Sales Growth
4.6 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Growth

5 AMERICAS

5.1 Americas Tyrosine Protein Kinase JAK1 Sales by Country
  5.1.1 Americas Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022)
  5.1.2 Americas Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022)
5.2 Americas Tyrosine Protein Kinase JAK1 Sales by Type
5.3 Americas Tyrosine Protein Kinase JAK1 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tyrosine Protein Kinase JAK1 Sales by Region
  6.1.1 APAC Tyrosine Protein Kinase JAK1 Sales by Region (2017-2022)
  6.1.2 APAC Tyrosine Protein Kinase JAK1 Revenue by Region (2017-2022)
6.2 APAC Tyrosine Protein Kinase JAK1 Sales by Type
6.3 APAC Tyrosine Protein Kinase JAK1 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Tyrosine Protein Kinase JAK1 by Country
  7.1.1 Europe Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022)
  7.1.2 Europe Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022)
7.2 Europe Tyrosine Protein Kinase JAK1 Sales by Type
7.3 Europe Tyrosine Protein Kinase JAK1 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tyrosine Protein Kinase JAK1 by Country
  8.1.1 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022)
8.2 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Type
8.3 Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tyrosine Protein Kinase JAK1
10.3 Manufacturing Process Analysis of Tyrosine Protein Kinase JAK1
10.4 Industry Chain Structure of Tyrosine Protein Kinase JAK1

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Tyrosine Protein Kinase JAK1 Distributors
11.3 Tyrosine Protein Kinase JAK1 Customer

12 WORLD FORECAST REVIEW FOR TYROSINE PROTEIN KINASE JAK1 BY GEOGRAPHIC REGION

12.1 Global Tyrosine Protein Kinase JAK1 Market Size Forecast by Region
  12.1.1 Global Tyrosine Protein Kinase JAK1 Forecast by Region (2023-2028)
  12.1.2 Global Tyrosine Protein Kinase JAK1 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tyrosine Protein Kinase JAK1 Forecast by Type
12.7 Global Tyrosine Protein Kinase JAK1 Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 AbbVie Inc
  13.1.1 AbbVie Inc Company Information
  13.1.2 AbbVie Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.1.3 AbbVie Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 AbbVie Inc Main Business Overview
  13.1.5 AbbVie Inc Latest Developments
13.2 Aclaris Therapeutics Inc
  13.2.1 Aclaris Therapeutics Inc Company Information
  13.2.2 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.2.3 Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Aclaris Therapeutics Inc Main Business Overview
  13.2.5 Aclaris Therapeutics Inc Latest Developments
13.3 Astellas Pharma Inc
  13.3.1 Astellas Pharma Inc Company Information
  13.3.2 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.3.3 Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Astellas Pharma Inc Main Business Overview
  13.3.5 Astellas Pharma Inc Latest Developments
13.4 AstraZeneca Plc
  13.4.1 AstraZeneca Plc Company Information
  13.4.2 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Offered
  13.4.3 AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 AstraZeneca Plc Main Business Overview
  13.4.5 AstraZeneca Plc Latest Developments
13.5 Bristol-Myers Squibb Co
  13.5.1 Bristol-Myers Squibb Co Company Information
  13.5.2 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Offered
  13.5.3 Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Bristol-Myers Squibb Co Main Business Overview
  13.5.5 Bristol-Myers Squibb Co Latest Developments
13.6 Chipscreen Biosciences Ltd
  13.6.1 Chipscreen Biosciences Ltd Company Information
  13.6.2 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Offered
  13.6.3 Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Chipscreen Biosciences Ltd Main Business Overview
  13.6.5 Chipscreen Biosciences Ltd Latest Developments
13.7 CJ HealthCare Corp
  13.7.1 CJ HealthCare Corp Company Information
  13.7.2 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Offered
  13.7.3 CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 CJ HealthCare Corp Main Business Overview
  13.7.5 CJ HealthCare Corp Latest Developments
13.8 Concert Pharmaceuticals Inc
  13.8.1 Concert Pharmaceuticals Inc Company Information
  13.8.2 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.8.3 Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Concert Pharmaceuticals Inc Main Business Overview
  13.8.5 Concert Pharmaceuticals Inc Latest Developments
13.9 Eli Lilly and Co
  13.9.1 Eli Lilly and Co Company Information
  13.9.2 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Offered
  13.9.3 Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Eli Lilly and Co Main Business Overview
  13.9.5 Eli Lilly and Co Latest Developments
13.10 Galapagos NV
  13.10.1 Galapagos NV Company Information
  13.10.2 Galapagos NV Tyrosine Protein Kinase JAK1 Product Offered
  13.10.3 Galapagos NV Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Galapagos NV Main Business Overview
  13.10.5 Galapagos NV Latest Developments
13.11 Incyte Corp
  13.11.1 Incyte Corp Company Information
  13.11.2 Incyte Corp Tyrosine Protein Kinase JAK1 Product Offered
  13.11.3 Incyte Corp Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Incyte Corp Main Business Overview
  13.11.5 Incyte Corp Latest Developments
13.12 Japan Tobacco Inc
  13.12.1 Japan Tobacco Inc Company Information
  13.12.2 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.12.3 Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Japan Tobacco Inc Main Business Overview
  13.12.5 Japan Tobacco Inc Latest Developments
13.13 Jiangsu Hengrui Medicine Co Ltd
  13.13.1 Jiangsu Hengrui Medicine Co Ltd Company Information
  13.13.2 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Offered
  13.13.3 Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Jiangsu Hengrui Medicine Co Ltd Main Business Overview
  13.13.5 Jiangsu Hengrui Medicine Co Ltd Latest Developments
13.14 Nissan Chemical Industries Ltd
  13.14.1 Nissan Chemical Industries Ltd Company Information
  13.14.2 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Offered
  13.14.3 Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.14.4 Nissan Chemical Industries Ltd Main Business Overview
  13.14.5 Nissan Chemical Industries Ltd Latest Developments
13.15 Pfizer Inc
  13.15.1 Pfizer Inc Company Information
  13.15.2 Pfizer Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.15.3 Pfizer Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.15.4 Pfizer Inc Main Business Overview
  13.15.5 Pfizer Inc Latest Developments
13.16 Portola Pharmaceuticals Inc
  13.16.1 Portola Pharmaceuticals Inc Company Information
  13.16.2 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.16.3 Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.16.4 Portola Pharmaceuticals Inc Main Business Overview
  13.16.5 Portola Pharmaceuticals Inc Latest Developments
13.17 Sareum Holdings Plc
  13.17.1 Sareum Holdings Plc Company Information
  13.17.2 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Offered
  13.17.3 Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.17.4 Sareum Holdings Plc Main Business Overview
  13.17.5 Sareum Holdings Plc Latest Developments
13.18 Theravance Biopharma Inc
  13.18.1 Theravance Biopharma Inc Company Information
  13.18.2 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Offered
  13.18.3 Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.18.4 Theravance Biopharma Inc Main Business Overview
  13.18.5 Theravance Biopharma Inc Latest Developments
13.19 Vectura Group Plc
  13.19.1 Vectura Group Plc Company Information
  13.19.2 Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Offered
  13.19.3 Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales, Revenue, Price and Gross Margin (2020-2022)
  13.19.4 Vectura Group Plc Main Business Overview
  13.19.5 Vectura Group Plc Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Tyrosine Protein Kinase JAK1 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Tyrosine Protein Kinase JAK1 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AZD-4205
Table 4. Major Players of Baricitinib
Table 5. Major Players of Cerdulatinib
Table 6. Major Players of CJ-15314
Table 7. Major Players of Others
Table 8. Global Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)
Table 10. Global Tyrosine Protein Kinase JAK1 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2017-2022)
Table 12. Global Tyrosine Protein Kinase JAK1 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)
Table 15. Global Tyrosine Protein Kinase JAK1 Revenue by Application (2017-2022)
Table 16. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application (2017-2022)
Table 17. Global Tyrosine Protein Kinase JAK1 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Tyrosine Protein Kinase JAK1 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Company (2020-2022)
Table 20. Global Tyrosine Protein Kinase JAK1 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company (2020-2022)
Table 22. Global Tyrosine Protein Kinase JAK1 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Tyrosine Protein Kinase JAK1 Producing Area Distribution and Sales Area
Table 24. Players Tyrosine Protein Kinase JAK1 Products Offered
Table 25. Tyrosine Protein Kinase JAK1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Tyrosine Protein Kinase JAK1 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Tyrosine Protein Kinase JAK1 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Tyrosine Protein Kinase JAK1 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Tyrosine Protein Kinase JAK1 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Tyrosine Protein Kinase JAK1 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2017-2022)
Table 38. Americas Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Tyrosine Protein Kinase JAK1 Revenue Market Share by Country (2017-2022)
Table 40. Americas Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)
Table 42. Americas Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)
Table 44. APAC Tyrosine Protein Kinase JAK1 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Region (2017-2022)
Table 46. APAC Tyrosine Protein Kinase JAK1 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Tyrosine Protein Kinase JAK1 Revenue Market Share by Region (2017-2022)
Table 48. APAC Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)
Table 50. APAC Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)
Table 52. Europe Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2017-2022)
Table 54. Europe Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Tyrosine Protein Kinase JAK1 Revenue Market Share by Country (2017-2022)
Table 56. Europe Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)
Table 58. Europe Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Tyrosine Protein Kinase JAK1
Table 69. Key Market Challenges & Risks of Tyrosine Protein Kinase JAK1
Table 70. Key Industry Trends of Tyrosine Protein Kinase JAK1
Table 71. Tyrosine Protein Kinase JAK1 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Tyrosine Protein Kinase JAK1 Distributors List
Table 74. Tyrosine Protein Kinase JAK1 Customer List
Table 75. Global Tyrosine Protein Kinase JAK1 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Tyrosine Protein Kinase JAK1 Sales Market Forecast by Region
Table 77. Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Tyrosine Protein Kinase JAK1 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Tyrosine Protein Kinase JAK1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Tyrosine Protein Kinase JAK1 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Tyrosine Protein Kinase JAK1 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Tyrosine Protein Kinase JAK1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Tyrosine Protein Kinase JAK1 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Tyrosine Protein Kinase JAK1 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Tyrosine Protein Kinase JAK1 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Tyrosine Protein Kinase JAK1 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Tyrosine Protein Kinase JAK1 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Tyrosine Protein Kinase JAK1 Revenue Market Share Forecast by Application (2023-2028)
Table 95. AbbVie Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 96. AbbVie Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 97. AbbVie Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. AbbVie Inc Main Business
Table 99. AbbVie Inc Latest Developments
Table 100. Aclaris Therapeutics Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 101. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 102. Aclaris Therapeutics Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Aclaris Therapeutics Inc Main Business
Table 104. Aclaris Therapeutics Inc Latest Developments
Table 105. Astellas Pharma Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 106. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 107. Astellas Pharma Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Astellas Pharma Inc Main Business
Table 109. Astellas Pharma Inc Latest Developments
Table 110. AstraZeneca Plc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 111. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Product Offered
Table 112. AstraZeneca Plc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. AstraZeneca Plc Main Business
Table 114. AstraZeneca Plc Latest Developments
Table 115. Bristol-Myers Squibb Co Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 116. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Product Offered
Table 117. Bristol-Myers Squibb Co Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Bristol-Myers Squibb Co Main Business
Table 119. Bristol-Myers Squibb Co Latest Developments
Table 120. Chipscreen Biosciences Ltd Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 121. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Product Offered
Table 122. Chipscreen Biosciences Ltd Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Chipscreen Biosciences Ltd Main Business
Table 124. Chipscreen Biosciences Ltd Latest Developments
Table 125. CJ HealthCare Corp Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 126. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Product Offered
Table 127. CJ HealthCare Corp Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. CJ HealthCare Corp Main Business
Table 129. CJ HealthCare Corp Latest Developments
Table 130. Concert Pharmaceuticals Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 131. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 132. Concert Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Concert Pharmaceuticals Inc Main Business
Table 134. Concert Pharmaceuticals Inc Latest Developments
Table 135. Eli Lilly and Co Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 136. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Product Offered
Table 137. Eli Lilly and Co Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Eli Lilly and Co Main Business
Table 139. Eli Lilly and Co Latest Developments
Table 140. Galapagos NV Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 141. Galapagos NV Tyrosine Protein Kinase JAK1 Product Offered
Table 142. Galapagos NV Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. Galapagos NV Main Business
Table 144. Galapagos NV Latest Developments
Table 145. Incyte Corp Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 146. Incyte Corp Tyrosine Protein Kinase JAK1 Product Offered
Table 147. Incyte Corp Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Incyte Corp Main Business
Table 149. Incyte Corp Latest Developments
Table 150. Japan Tobacco Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 151. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 152. Japan Tobacco Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Japan Tobacco Inc Main Business
Table 154. Japan Tobacco Inc Latest Developments
Table 155. Jiangsu Hengrui Medicine Co Ltd Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 156. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Product Offered
Table 157. Jiangsu Hengrui Medicine Co Ltd Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. Jiangsu Hengrui Medicine Co Ltd Main Business
Table 159. Jiangsu Hengrui Medicine Co Ltd Latest Developments
Table 160. Nissan Chemical Industries Ltd Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 161. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Product Offered
Table 162. Nissan Chemical Industries Ltd Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Nissan Chemical Industries Ltd Main Business
Table 164. Nissan Chemical Industries Ltd Latest Developments
Table 165. Pfizer Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 166. Pfizer Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 167. Pfizer Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 168. Pfizer Inc Main Business
Table 169. Pfizer Inc Latest Developments
Table 170. Portola Pharmaceuticals Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 171. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 172. Portola Pharmaceuticals Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 173. Portola Pharmaceuticals Inc Main Business
Table 174. Portola Pharmaceuticals Inc Latest Developments
Table 175. Sareum Holdings Plc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 176. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Product Offered
Table 177. Sareum Holdings Plc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 178. Sareum Holdings Plc Main Business
Table 179. Sareum Holdings Plc Latest Developments
Table 180. Theravance Biopharma Inc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 181. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Product Offered
Table 182. Theravance Biopharma Inc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 183. Theravance Biopharma Inc Main Business
Table 184. Theravance Biopharma Inc Latest Developments
Table 185. Vectura Group Plc Basic Information, Tyrosine Protein Kinase JAK1 Manufacturing Base, Sales Area and Its Competitors
Table 186. Vectura Group Plc Tyrosine Protein Kinase JAK1 Product Offered
Table 187. Vectura Group Plc Tyrosine Protein Kinase JAK1 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 188. Vectura Group Plc Main Business
Table 189. Vectura Group Plc Latest Developments

LIST OF FIGURES

Figure 1. Picture of Tyrosine Protein Kinase JAK1
Figure 2. Tyrosine Protein Kinase JAK1 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tyrosine Protein Kinase JAK1 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Tyrosine Protein Kinase JAK1 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Tyrosine Protein Kinase JAK1 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AZD-4205
Figure 10. Product Picture of Baricitinib
Figure 11. Product Picture of Cerdulatinib
Figure 12. Product Picture of CJ-15314
Figure 13. Product Picture of Others
Figure 14. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Type in 2021
Figure 15. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Type (2017-2022)
Figure 16. Tyrosine Protein Kinase JAK1 Consumed in Cutaneous Lupus Erythematosus
Figure 17. Global Tyrosine Protein Kinase JAK1 Market: Cutaneous Lupus Erythematosus (2017-2022) & (K Pcs)
Figure 18. Tyrosine Protein Kinase JAK1 Consumed in Eosinophilia
Figure 19. Global Tyrosine Protein Kinase JAK1 Market: Eosinophilia (2017-2022) & (K Pcs)
Figure 20. Tyrosine Protein Kinase JAK1 Consumed in Hairy Cell Leukemia
Figure 21. Global Tyrosine Protein Kinase JAK1 Market: Hairy Cell Leukemia (2017-2022) & (K Pcs)
Figure 22. Tyrosine Protein Kinase JAK1 Consumed in Others
Figure 23. Global Tyrosine Protein Kinase JAK1 Market: Others (2017-2022) & (K Pcs)
Figure 24. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Application (2017-2022)
Figure 25. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Application in 2021
Figure 26. Tyrosine Protein Kinase JAK1 Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Company in 2021
Figure 28. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Geographic Region in 2021
Figure 30. Global Tyrosine Protein Kinase JAK1 Sales Market Share by Region (2017-2022)
Figure 31. Global Tyrosine Protein Kinase JAK1 Revenue Market Share by Country/Region in 2021
Figure 32. Americas Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)
Figure 33. Americas Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)
Figure 34. APAC Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)
Figure 35. APAC Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)
Figure 36. Europe Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)
Figure 37. Europe Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales 2017-2022 (K Pcs)
Figure 39. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue 2017-2022 ($ Millions)
Figure 40. Americas Tyrosine Protein Kinase JAK1 Sales Market Share by Country in 2021
Figure 41. Americas Tyrosine Protein Kinase JAK1 Revenue Market Share by Country in 2021
Figure 42. United States Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Tyrosine Protein Kinase JAK1 Sales Market Share by Region in 2021
Figure 47. APAC Tyrosine Protein Kinase JAK1 Revenue Market Share by Regions in 2021
Figure 48. China Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Tyrosine Protein Kinase JAK1 Sales Market Share by Country in 2021
Figure 55. Europe Tyrosine Protein Kinase JAK1 Revenue Market Share by Country in 2021
Figure 56. Germany Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Tyrosine Protein Kinase JAK1 Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Tyrosine Protein Kinase JAK1 Revenue Market Share by Country in 2021
Figure 63. Egypt Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Tyrosine Protein Kinase JAK1 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Tyrosine Protein Kinase JAK1 in 2021
Figure 69. Manufacturing Process Analysis of Tyrosine Protein Kinase JAK1
Figure 70. Industry Chain Structure of Tyrosine Protein Kinase JAK1
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles


More Publications